Christopher B. Hughes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Christopher B. Hughes has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Cemal Burcin Taner
Department of Transplantation, Mayo Clinic, Jacksonville, FL, USA
1 shared publication D.L. Willingham
1 shared publication- Denise M. Harnois
Division of Gastroenterology & Hepatology, Mayo Clinic, Jacksonville, Florida, USA
1 shared publication H. Bonatti
Mayo Clinic College of Medicine
1 shared publicationH.P. Grewal
1 shared publicationHugo Bonatti
Department of Transplantation, Mayo Clinic, Jacksonville, FL, USA
1 shared publication
Latest Publications
- 1 November 2009
- Published by Elsevier in Transplantation Proceedings
- Vol. 41 (9) , 3769-3771
Polycystic Liver Disease and Liver Transplantation: Single-Institution Experience
- 1 November 2009
- Published by Elsevier in Transplantation Proceedings
- Vol. 41 (9) , 3769-3771
Polycystic Liver Disease and Liver Transplantation: Single-Institution Experience
- Open Access
- 21 December 2004
- Published by Frontiers Media SA in Transplant International
- Vol. 18 (1) , 52-55
Gallbladder cancer and liver transplantation
Gallbladder cancer is the fifth most common malignancy of the gastrointestinal tract. Gallbladder cancer is found incidentally at the time of cholecystectomy in 0.35% of patients. Two previous isolated case reports of incidentally found gallbladder cancer in hepatectomy specimens following liver transplantation (LT) showed no adverse outcomes. We reviewed the outcome of four patients. Three patients had end‐stage liver disease secondary to primary sclerosing cholangitis and one patient had cryptogenic cirrhosis. Gallbladder cancer was removed at cholecystectomy in one patient 11 months prior to transplant. One patient had suspected gallbladder cancer prior to LT by ultrasound and CT imaging, as well as a rising CA 19‐9. The other two patients had incidentally identified gallbladder cancer. Median follow‐up was 30 months. There has been no evidence of recurrence and patient survival was 100%. Early gallbladder cancer is not a contraindication for LT, however further follow‐up is needed.
- 21 December 2004
- Published by Frontiers Media SA in Transplant International
- Vol. 18 (1) , 52-55
Open AccessGallbladder cancer and liver transplantation
Gallbladder cancer is the fifth most common malignancy of the gastrointestinal tract. Gallbladder cancer is found incidentally at the time of cholecystectomy in 0.35% of patients. Two previous isolated case reports of incidentally found gallbladder cancer in hepatectomy specimens following liver transplantation (LT) showed no adverse outcomes. We reviewed the outcome of four patients. Three patients had end‐stage liver disease secondary to primary sclerosing cholangitis and one patient had cryptogenic cirrhosis. Gallbladder cancer was removed at cholecystectomy in one patient 11 months prior to transplant. One patient had suspected gallbladder cancer prior to LT by ultrasound and CT imaging, as well as a rising CA 19‐9. The other two patients had incidentally identified gallbladder cancer. Median follow‐up was 30 months. There has been no evidence of recurrence and patient survival was 100%. Early gallbladder cancer is not a contraindication for LT, however further follow‐up is needed.